Filing excerpt
Mr. Zoiss ceased to serve as President of L3Harris’ Space & Airborne Systems segment at the end of L3Harris’ fiscal year on January 2, 2026.
sec.gov/Archives/edgar/data/202058/000020205826000002/hrs-20260102.htmRead the full source
L3Harris8-K: Succession announcement
L3Harris Segment President Departs Amid Major Business Reorganization from 4 to 3 Segments
What happened
The departure of Edward Zoiss as President of the Space & Airborne Systems segment coincides with a company-wide reorganization from four to three business units.
Source
Other signals in this filing (3)
- RestructuringL3Harris reorganizes from four to three business segments effective January 2026Restructuring
- Restructuring chargeL3Harris announces major business reorganization, consolidating from four to three segments.Restructuring charge
- Governance changeEdward Zoiss appointed VP, Engineering & Innovation at L3Harris as of January 2026.Governance change
Extracted by Autobound
From the Signal API record- Signal
- 8-K: Succession announcement
What this signalsFilings often name leadership changes, deals and spending plans.
- Form
- 8-K
- Filed
- Jan 5, 2026
More from L3Harris
- Facility expansionL3Harris Awarded $6 Billion Seven-Year Contract to Expand THAAD Missile Defense Propulsion ProductionFacility expansion
- PatentsL3Harris Technologies, Inc.'s patent output is steady: 33 grants in the past year, 3 in the past 30 days.Patents
- Federal contracts$350K federal contract from Department of CommerceFederal contracts
- In developmentL3Harris Awarded $876M Modification for Navy Low Band Jammer WorkIn development
- PartnershipL3Harris Technologies : Partners with Naval Air Warfare Center to Increase Tomahawk ProductionPartnership
- RedditL3Harris was named as a possible third-party maintainer for the FAA's FTI telecommunications system, which suffered a primary circuit failure causing a major travel meltdown.Reddit
More 8-K signals at other companies
- SEC 8-K4D Molecular Therapeutics, Inc.4D Molecular Therapeutics initiates Phase 3 trial directly challenging competitor drug aflibercept.SEC 8-K
- SEC 8-KAdeia Inc.Adeia Inc. appoints new CEO Dipti Vachani, effective October 12, 2026, replacing outgoing CEO Paul E. Davis.SEC 8-K
- SEC 8-KAdicet Bio, Inc.Adicet Bio launching pivotal clinical trial in Q4 2026 after positive Phase 1 data for Prula-cel.SEC 8-K
The full record
From the Signal API recordDetails
- CIK
- 202058
- Accession number
- 0000202058-26-000002
- Timeframe
- Immediate
- Filing year
- 2026
- Why it matters
- Upcoming vendor review window
- Signal category
- Leadership
Extraction
- Confidence
- High
- Relevance
- 90%
- Sentiment
- Neutral
- Detected
- Feb 3, 2026
- signal_type
sec-8k- signal_subtype
successionAnnouncement
Use this data
Get every 8-K signal for L3Harris and the companies you sell to, in the tools you already use.
Ask Claude about it
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at L3Harris this week?”
Send it to your own tools
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Try it free
Sign up and spend your free credits on the companies you sell to.
Start Free1,000 free credits
The API returns more than this page shows
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the API
Signal
signal_nameValue in the APIassociationValue in the API
Start Free1,000 free creditsUse it in Claude via MCP
Show the full JSONHide the full JSONThe record on this page and the API request
GET /v1/signals/9130587b-2247-45dd-b4cb-5660317a49e9 returns this record as JSON. POST /v1/companies/enrich returns every signal for l3harris.com.
{
"signal_id": "9130587b-2247-45dd-b4cb-5660317a49e9",
"signal_type": "sec-8k",
"signal_subtype": "successionAnnouncement",
"detected_at": "2026-02-03T13:13:07.484+00:00",
"company": {
"name": "L3Harris",
"domain": "l3harris.com"
},
"data": {
"detail": "The departure of Edward Zoiss as President of the Space & Airborne Systems segment coincides with a company-wide reorganization from four to three business units. This dual disruption of leadership transition and structural change creates significant vendor opportunities as new leadership is sought and operational processes are realigned.",
"metrics": {
"timeframe": "immediate"
},
"summary": "L3Harris Segment President Departs Amid Major Business Reorganization from 4 to 3 Segments",
"excerpts": "Mr. Zoiss ceased to serve as President of L3Harris’ Space & Airborne Systems segment at the end of L3Harris’ fiscal year on January 2, 2026.",
"relevance": 0.9,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/202058/000020205826000002/hrs-20260102.htm",
"filing_date": "2026-01-05",
"filing_year": 2026,
"sales_relevance": "Upcoming vendor review window",
"signal_category": "leadership"
}
}
curl https://signals.autobound.ai/v1/signals/9130587b-2247-45dd-b4cb-5660317a49e9 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"l3harris.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.